Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Invacare Ekes Out 2012 Profit, Despite 'Most Challenging Year'

February 13, 2013 3:25 pm | by Mass Device | News | Comments

Invacare manages a swing to 2012 black despite what CEO Gerald Blouch called 1 of "the most challenging" in the company's history. Invacare (NYSE:IVC) weathered what CEO Gerald Blouch called "1 of the most challenging in the company's history" and managed to eke out a small profit.

Tigre Becomes First Heart Safe City in Argentina by Implementing ZOLL AED Plus

February 13, 2013 2:59 pm | by The Associated Press | News | Comments

CHELMSFORD, Mass.--(BUSINESS WIRE)--Feb 13, 2013--ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the city of Tigre in the Province of Buenos Aires, has installed ZOLL AED Plus ® units in public areas throughout this popular tourist...

TOPICS:

Consistently Good Acute Stroke Outcomes and Device Safety With The Penumbra System™ Again Confirmed In NIH-Funded Study

February 13, 2013 1:41 pm | by The Associated Press | News | Comments

ALAMEDA, Calif.--(BUSINESS WIRE)--Feb 13, 2013--Last week Joseph Broderick, MD, Principle Investigator of the Interventional Management Of Stroke III (IMS III) Trial, announced the overall results and major subgroup analyses at the International Stroke Conference (ISC) in Honolulu, Hawaii.

TOPICS:
Advertisement

Frost & Sullivan Acknowledges that PKC's Biosensors are Expected to Become the New Industry Standard in Pathogen Testing

February 13, 2013 12:21 pm | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif. , Feb. 13, 2013 /- Based on its recent analysis of the global biosensors market, Frost & Sullivan recognizes Pharmaco-Kinesis Corporation (PKC) with the 2013 Global Frost & Sullivan Award for New Product Innovation. The company has set a new standard in the biosensors market with its innovative, highly sensitive biosensor. This unique, multi-pathogen...

TOPICS:

Loma Vista Medical Reports That It is Ramping up Sales in U.S. and Europe of its FDA-Cleared and CE-Marked TRUE Dilatation™ Balloon Valvuloplasty Catheter Specifically Designed to Reduce ‘Rapid Pacing’ Time and Prevent Balloon Failure

February 13, 2013 9:34 am | by The Associated Press | News | Comments

BURLINGAME, Calif.--(BUSINESS WIRE)--Feb 13, 2013--Loma Vista Medical announced today that it has established a direct sales force in the United States and has scaled its partnerships with seven (7) distributors in Europe in order to keep pace with the rapidly increasing demand for its FDA-cleared and CE-marked...

Medtronic Announces FDA Approval and Launch of Its Advisa MRI Pacemaker System

February 13, 2013 9:06 am | by The Associated Press | News | Comments

Second-generation MR-Conditional Pacemaker Combines Advanced Pacing Technology with MRI Access MINNEAPOLIS - February 13, 2013 - Showcasing its leadership position in pacing technologies, Medtronic, Inc. (NYSE: MDT), today announced the...

TOPICS:

Invuity Bolsters Executive Team; Adds Industry Veterans in Key Finance and Commercial Roles

February 13, 2013 9:01 am | by The Associated Press | News | Comments

Invuity, a leading developer of advanced visualization devices for minimally invasive surgery, announced that it has named Michael J. Gandy as Chief Financial Officer and Robert E. Gerberich as Vice President, Sales & Marketing.  Both have more than two decades of experience in the ...

TOPICS:

Hip Implant Costs Are a Medical Mystery, Study Says

February 13, 2013 7:29 am | by Mass Device | News | Comments

A Washington University project intended to uncover the cost of hip replacement procedures made the unindented discovery that around half of the hospitals could provide no estimates. Among the more than 100 hospitals contacted by the researcher, those that could provide figures ranged from around $11,000 to more than $125,000.

TOPICS:
Advertisement

Increasing Surgical Volumes to Boost Use of Tissue Sealants and Topical Haemostats, Says Frost & Sullivan

February 13, 2013 4:19 am | by Bio-Medicine.Org | News | Comments

LONDON , Feb. 13, 2013 /- The need for quality care, especially for a rapidly ageing population, is a strong driving factor for the tissue sealants and haemostats market in Western Europe . Technologically advanced products that enhance surgical efficiency and patient safety will also boost market prospects. New analysis from Frost & Sullivan ( http://www.healt...

TOPICS:

Given Imaging Reports Fourth Quarter and Fiscal Year 2012 Financial Results

February 12, 2013 5:57 pm | by The Associated Press | News | Comments

Given Imaging Ltd. (NASDAQ: GIVN) today announced financial results for the fourth quarter and fiscal year ended December 31, 2012. Revenues were $48.7 million in the fourth quarter of 2012, compared to $48.5 million in the fourth quarter of 2011. Gross margin on a GAAP-basis in the...

AACR Hosts Congressional Briefing on Cancer Progress, NIH Funding

February 12, 2013 5:03 pm | by AACR | News | Comments

The American Association for Cancer Research hosted a briefing on Feb. 12 for members of Congress and their legislative staffs that highlighted progress in cancer research and treatment as well as challenges created by decreased levels of funding. The briefing was held in the Rayburn Building on Capitol Hill as the threat of sequestration looms.

TOPICS:

FDA Slaps Highest Risk Label on St. Jude Medical's Amplatzer TorqVue FX Recall

February 12, 2013 4:26 pm | by Mass Device | News | Comments

St. Jude Medical recalls its Amplatzer TorqVue FX delivery system over concerns about fractures in the core wire. The FDA issued the highest-risk label on St. Jude Medical's (NYSE:STJ) recall of its Amplatzer TorqVue FX delivery system. St. Jude recalled a component of its Amplatzer Occluder over concerns that part of the delivery system may fracture, potentially causing adverse consequences or even death.

Vatican Unveils Outgoing Pope Benedict's Secret Pacemaker

February 12, 2013 3:14 pm | by Mass Device | News | Comments

Vatican officials revealed today that Pope Benedict has had a pacemaker for years, and recently underwent surgery to replace the implant's battery. Vatican spokesman Rev. Federico Lombardi told reporters that the outgoing Pope had his pacemaker for "a long time" prior to being named Pope in 2005.

Medical Device Tax Will Cost Boston Scientific $75M this Year, CEO Says

February 12, 2013 2:33 pm | by Mass Device | News | Comments

Boston Scientific CEO Michael Mahoney tells investors that the new 2.3% medical device sales tax will cost the company about $75 million in 2013. Medtech giant Boston Scientific (NYSE:BSX) estimates that its 2013 medical device tax obligation will amount to around $75 million, president & CEO Michael Mahoney told an audience the company's analyst meeting in New York today.

TOPICS:

Terumo BCT Announces First Patient Enrolled in North American Clinical Trial of Mirasol® Pathogen Reduction Technology System

February 12, 2013 1:10 pm | by The Associated Press | News | Comments

LAKEWOOD, Colo.--(BUSINESS WIRE)--Feb 12, 2013--Terumo BCT announces that the first patient, in the ongoing PREPAReS (Pathogen Reduction Evaluation & Predictive Analytical Rating Score study) trial, has been enrolled in Canada. Sponsored by the Sanquin Blood Supply Foundation, Netherlands,...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading